Astellas Pharma and its US affiliate Astellas US have jointly filed a patent infringement lawsuit against Nycomed US (Nycomed) in the US, in response to its submission of an abbreviated new drug application for a generic version of Astellas 0.1% Tacrolimus ointment, which is sold under the trademark, Protopic.
Subscribe to our email newsletter
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.